132 related articles for article (PubMed ID: 12873983)
1. Recapitulation of the cellular xeroderma pigmentosum-variant phenotypes using short interfering RNA for DNA polymerase H.
Laposa RR; Feeney L; Cleaver JE
Cancer Res; 2003 Jul; 63(14):3909-12. PubMed ID: 12873983
[TBL] [Abstract][Full Text] [Related]
2. Overproduction of DNA polymerase eta does not raise the spontaneous mutation rate in diploid human fibroblasts.
King NM; Nikolaishvili-Feinberg N; Bryant MF; Luche DD; Heffernan TP; Simpson DA; Hanaoka F; Kaufmann WK; Cordeiro-Stone M
DNA Repair (Amst); 2005 Jun; 4(6):714-24. PubMed ID: 15886068
[TBL] [Abstract][Full Text] [Related]
3. The role of DNA polymerase eta in UV mutational spectra.
Choi JH; Pfeifer GP
DNA Repair (Amst); 2005 Feb; 4(2):211-20. PubMed ID: 15590329
[TBL] [Abstract][Full Text] [Related]
4. Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.
Akagi J; Masutani C; Kataoka Y; Kan T; Ohashi E; Mori T; Ohmori H; Hanaoka F
DNA Repair (Amst); 2009 May; 8(5):585-99. PubMed ID: 19157994
[TBL] [Abstract][Full Text] [Related]
5. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
6. DNA polymerase eta, the product of the xeroderma pigmentosum variant gene and a target of p53, modulates the DNA damage checkpoint and p53 activation.
Liu G; Chen X
Mol Cell Biol; 2006 Feb; 26(4):1398-413. PubMed ID: 16449651
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus mediated transduction of the human DNA polymerase eta cDNA.
Lima-Bessa KM; Chiganças V; Stary A; Kannouche P; Sarasin A; Armelini MG; de Fátima Jacysyn J; Amarante-Mendes GP; Cordeiro-Stone M; Cleaver JE; Menck CF
DNA Repair (Amst); 2006 Aug; 5(8):925-34. PubMed ID: 16798111
[TBL] [Abstract][Full Text] [Related]
8. Translesion replication in cisplatin-treated xeroderma pigmentosum variant cells is also caffeine-sensitive: features of the error-prone DNA polymerase(s) involved in UV-mutagenesis.
Yamada K; Takezawa J; Ezaki O
DNA Repair (Amst); 2003 Aug; 2(8):909-24. PubMed ID: 12893087
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of nucleotide excision repair defects between XPD-mutated fibroblasts derived from trichothiodystrophy and xeroderma pigmentosum patients.
Nishiwaki T; Kobayashi N; Iwamoto T; Yamamoto A; Sugiura S; Liu YC; Sarasin A; Okahashi Y; Hirano M; Ueno S; Mori T
DNA Repair (Amst); 2008 Dec; 7(12):1990-8. PubMed ID: 18817897
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum group E and DDB2, a smaller subunit of damage-specific DNA binding protein: proposed classification of xeroderma pigmentosum, Cockayne syndrome, and ultraviolet-sensitive syndrome.
Itoh T
J Dermatol Sci; 2006 Feb; 41(2):87-96. PubMed ID: 16325378
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
[TBL] [Abstract][Full Text] [Related]
12. The human POLH gene is not mutated, and is expressed in a cohort of patients with basal or squamous cell carcinoma of the skin.
Flanagan AM; Rafferty G; O'Neill A; Rynne L; Kelly J; McCann J; Carty MP
Int J Mol Med; 2007 Apr; 19(4):589-96. PubMed ID: 17334634
[TBL] [Abstract][Full Text] [Related]
13. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta.
Diaz M; Watson NB; Turkington G; Verkoczy LK; Klinman NR; McGregor WG
Mol Cancer Res; 2003 Sep; 1(11):836-47. PubMed ID: 14517346
[TBL] [Abstract][Full Text] [Related]
14. Gene transduction in skin cells: preventing cancer in xeroderma pigmentosum mice.
Marchetto MC; Muotri AR; Burns DK; Friedberg EC; Menck CF
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17759-64. PubMed ID: 15598745
[TBL] [Abstract][Full Text] [Related]
15. Functional lentiviral vectors for xeroderma pigmentosum gene therapy.
Marchetto MC; Correa RG; Menck CF; Muotri AR
J Biotechnol; 2006 Dec; 126(4):424-30. PubMed ID: 16857285
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients.
Broughton BC; Cordonnier A; Kleijer WJ; Jaspers NG; Fawcett H; Raams A; Garritsen VH; Stary A; Avril MF; Boudsocq F; Masutani C; Hanaoka F; Fuchs RP; Sarasin A; Lehmann AR
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):815-20. PubMed ID: 11773631
[TBL] [Abstract][Full Text] [Related]
17. Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene.
Yuasa M; Masutani C; Eki T; Hanaoka F
Oncogene; 2000 Sep; 19(41):4721-8. PubMed ID: 11032022
[TBL] [Abstract][Full Text] [Related]
18. Remarkable induction of UV-signature mutations at the 3'-cytosine of dipyrimidine sites except at 5'-TCG-3' in the UVB-exposed skin epidermis of xeroderma pigmentosum variant model mice.
Ikehata H; Chang Y; Yokoi M; Yamamoto M; Hanaoka F
DNA Repair (Amst); 2014 Oct; 22():112-22. PubMed ID: 25128761
[TBL] [Abstract][Full Text] [Related]
19. Role of DNA polymerase eta in the UV mutation spectrum in human cells.
Stary A; Kannouche P; Lehmann AR; Sarasin A
J Biol Chem; 2003 May; 278(21):18767-75. PubMed ID: 12644471
[TBL] [Abstract][Full Text] [Related]
20. Properties of an xeroderma pigmentosum revertant cell line expressing endonuclease V.
Green AP; deRiel JK; Henderson E
Biochem Biophys Res Commun; 1993 Jan; 190(1):111-7. PubMed ID: 7678487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]